JAMA Network Open

JAMA Network Open is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.

[JAMA Network Open @JAMANetworkOpen]

From @JAMA_current: Among veterans with stable #CoronaryArteryDisease, upfront #PercutaneousCoronaryIntervention plus optimal medical therapy did not reduce long-term death or myocardial infarction vs optimal medical therapy alone.

https://t.co/wRZ6Lhg8Zi

#ScientificSessions26

[JAMA Network Open @JAMANetworkOpen]

💬 Editorial from @JAMA_current: In patients with stable #CoronaryArteryDisease and at least moderate inducible ischemia, long-term follow-up from #ISCHEMIA supports a medical therapy–first approach for most patients.

https://t.co/StIhwN5iJV

#ScientificSessions26

[JAMA Network Open @JAMANetworkOpen]

📊 Research Summary from @JAMA_current: Long-term follow-up in #ISCHEMIA-EXTEND indicates no significant all-cause mortality difference between initial invasive and conservative management of stable #CoronaryDisease.

https://t.co/6TLmsMPSN6

#ScientificSessions26

[JAMA Network Open @JAMANetworkOpen]

From @JAMA_current: Among patients with stable #CoronaryDisease and moderate or severe ischemia, an initial invasive strategy did not improve long-term survival vs an initial conservative strategy.

https://t.co/pvPAbdQUCu

#ScientificSessions26

[JAMA Network Open @JAMANetworkOpen]

From @JAMACardio: #AI analysis of clinical notes identified infrequent low-density lipoprotein cholesterol target documentation and heterogeneous reasons for nonescalation of #LipidLoweringTherapy in secondary prevention.

https://t.co/INApyWjoZo

#ScientificSessions26

[JAMA Network Open @JAMANetworkOpen]

💬 Editorial from @JAMA_current: An individualized treatment approach for #ObstructiveSleepApnea may combine weight-reducing therapy with positive airway pressure, oral appliances, or other airway-directed treatments.

https://t.co/hUgvMMSoBl

#ScientificSessions26

[JAMA Network Open @JAMANetworkOpen]

📊 Research Summary from @JAMA_current: In 2 trials of adults with moderate to severe #ObstructiveSleepApnea and excess weight, oral orforglipron improved sleep-disordered breathing, body weight, and hypoxic burden.

https://t.co/l3ln7vHcss

#ScientificSessions26

[JAMA Network Open @JAMANetworkOpen]

#ScientificSessions26 from @JAMA_current: Oral #Orforglipron improved apnea-hypopnea index, hypoxic burden, and body weight vs placebo in adults with #ObstructiveSleepApnea and obesity or overweight, w/ gastrointestinal adverse events reported more often.

https://t.co/aIs5LQ0HSg

[JAMA Network Open @JAMANetworkOpen]

@JAMA_current 📣 Stay connected with the JAMA Network at #ScientificSessions26!

Explore the latest cardiovascular research, featured articles, editor sessions, and attendee resources from the JAMA Network: https://t.co/XWNJuoWoe6

[JAMA Network Open @JAMANetworkOpen]

#ScientificSessions26 from @JAMA_current: Long-term follow-up in #ISCHEMIA-EXTEND indicates no significant all-cause mortality difference between initial invasive and conservative management of stable #CoronaryDisease.

https://t.co/2DwZ0zTwZO

[JAMA Network Open @JAMANetworkOpen]

@JAMA_current 📊 Research Summary: Among patients with stable #CoronaryDisease and moderate or severe ischemia, an initial invasive strategy did not improve long-term survival vs an initial conservative strategy.

https://t.co/Wl7A3TivcV

#ScientificSessions26

[JAMA Network Open @JAMANetworkOpen]

@JAMA_current 📣 Stay connected with the JAMA Network at #ScientificSessions26!

Explore the latest cardiovascular research, featured articles, editor sessions, and attendee resources from the JAMA Network: https://t.co/aKeomtU5pY

[JAMA Network Open @JAMANetworkOpen]

From @JAMA_current: Among veterans with stable #CoronaryArteryDisease, upfront #PercutaneousCoronaryIntervention plus optimal medical therapy did not reduce long-term death or myocardial infarction vs optimal medical therapy alone.

https://t.co/LQThijHiOY

#ScientificSessions26

[JAMA Network Open @JAMANetworkOpen]

💬 Editorial from @JAMA_current: In patients with stable #CoronaryArteryDisease and at least moderate inducible ischemia, long-term follow-up from #ISCHEMIA supports a medical therapy–first approach for most patients.

https://t.co/UONlsMwntj

#ScientificSessions26

[JAMA Network Open @JAMANetworkOpen]

📊 Research Summary from @JAMA_current: Long-term follow-up in #ISCHEMIA-EXTEND indicates no significant all-cause mortality difference between initial invasive and conservative management of stable #CoronaryDisease.

https://t.co/9RSvqM13rm

#ScientificSessions26

[JAMA Network Open @JAMANetworkOpen]

Presented at #ScientificSessions26 from @JAMA_current: Among patients with stable #CoronaryDisease and moderate or severe ischemia, an initial invasive strategy did not improve long-term survival vs an initial conservative strategy.

https://t.co/ZXvSk579ZP

[JAMA Network Open @JAMANetworkOpen]

@JAMACardio 📣 Stay connected with the JAMA Network at #ScientificSessions26!

Explore the latest cardiovascular research, featured articles, editor sessions, and attendee resources from the JAMA Network: https://t.co/Rg6ZfTonhf

[JAMA Network Open @JAMANetworkOpen]

#ScientificSessions26 from @JAMACardio: #AI analysis of clinical notes identified infrequent low-density lipoprotein cholesterol target documentation and heterogeneous reasons for nonescalation of #LipidLoweringTherapy in secondary prevention.

https://t.co/uDUep1fXw2

[JAMA Network Open @JAMANetworkOpen]

💬 Editorial from @JAMA_current: In patients with stable #CoronaryArteryDisease and at least moderate inducible ischemia, long-term follow-up from #ISCHEMIA supports a medical therapy–first approach for most patients.

https://t.co/Yk5vTGXnLK

#ScientificSessions26

[JAMA Network Open @JAMANetworkOpen]

📊 Research Summary from @JAMA_current: Long-term follow-up in #ISCHEMIA-EXTEND indicates no significant all-cause mortality difference between initial invasive and conservative management of stable #CoronaryDisease.

https://t.co/vvl9BjTWEm

#ScientificSessions26